Cargando…

Non-Bismuth Quadruple Therapy, Sequential Therapy or High-Dose Esomeprazole and Amoxicillin Dual Therapy for First-Line Helicobacter pylori Eradication: A Prospective Randomized Study

Aim: The study aims were to evaluate and compare the effectiveness and safety of non-bismuth quadruple therapy with sequential therapy and dual therapy with high dose esomeprazole and amoxicillin as an empirical first-line approach to eradicate Helicobacter pylori infection. Patients and methods: Pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeriouh, Meriem, Elmekkaoui, Amine, Bouqfar, Mouna, Zazour, Abdelkrim, Khannoussi, Wafaa, Kharrasse, Ghizlane, Abda, Naima, Ismaili, Zahi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781545/ https://www.ncbi.nlm.nih.gov/pubmed/33409077 http://dx.doi.org/10.7759/cureus.11837

Ejemplares similares

Colonic schistosomiasis: A case report
por: Koulali, Hajar, et al.
Publicado: (2022)

Abdominal Inflammatory Myofibroblastic Tumour Presenting as a Pancreatic Mass: A Case Report
por: Taiymi, Afafe, et al.
Publicado: (2023)

A rare case report of an adult with down syndrome and gallbladder cancer
por: Rais, Kaouthar, et al.
Publicado: (2022)

Solitary pancreatic metastasis from squamous cell lung carcinoma: A case report and review of literature
por: Rais, Kaouthar, et al.
Publicado: (2022)

Spontaneous Rupture of Hepatocellular Carcinoma With Fatal Outcome in a Patient Taking Direct-Acting Antivirals
por: Dendane, Youness, et al.
Publicado: (2023)

Association between pancreatic cancer and diabetes: insights from a retrospective cohort study
por: Amri, Fakhrddine, et al.
Publicado: (2023)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial
por: Mei, Hao, et al.
Publicado: (2022)

Primary pancreatic lymphoma: Report of 4 cases with literature review
por: Lamrani, Fatima Zahra, et al.
Publicado: (2023)

Prevalence of hepatitis B and C in blood transfusion center, Oujda Morocco (2013-2015)
por: Boubker, Samira, et al.
Publicado: (2019)

Signet-ring cell carcinoma of the caecum: A case report
por: Rahaoui, Maissae, et al.
Publicado: (2023)

Upper gastrointestinal bleeding revealing a Bouveret syndrome: A case report
por: Amri, Fakhrddine, et al.
Publicado: (2023)

Eradication efficacy of high-dose amoxicillin and proton pump inhibitor compared with quadruple therapy contained bismuth in the treatment of Helicobacter pylori
por: Hajiani, Eskandar, et al.
Publicado: (2022)

Dual Therapy Trial Using Esomeprazole and Amoxicillin as Third-line Rescue Therapy for Helicobacter pylori Infection
por: Park, Hyun Kyung, et al.
Publicado: (2011)

Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
por: Lee, Ju Yup, et al.
Publicado: (2016)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)

Susceptibility-guided bismuth quadruple therapies for resistant Helicobacter pylori infections
por: Yang, Tiankuo, et al.
Publicado: (2020)

Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy
por: Moon, Sang-Gon, et al.
Publicado: (2022)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

Wernicke’s Encephalopathy in a Patient With Crohn’s Disease: A Case Report
por: Adamou, Fatima, et al.
Publicado: (2023)

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
por: Jheng, Guang-Hong, et al.
Publicado: (2015)

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021)

Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and Helicobacter pylori Eradication Therapy
por: Sun, Yingchao, et al.
Publicado: (2022)

Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
por: Song, Zhiqiang, et al.
Publicado: (2019)

Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
por: Zhang, Ya-Wen, et al.
Publicado: (2018)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Primary tuberculoma of the liver: a case report and literature review
por: Kharrasse, Ghizlane, et al.
Publicado: (2014)

A rare cause of rectal bleeding in a 48-year-old lupus patient
por: El Eulj, Oumayma, et al.
Publicado: (2023)

High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study
por: Zullo, Angelo, et al.
Publicado: (2015)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2020)

Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori
por: Zhang, Lingyun, et al.
Publicado: (2019)

The efficacy and safety of furazolidone-bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotic supplementation
por: Noorbakhsh, Nafeh, et al.
Publicado: (2022)

Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency
por: Lee, Moon Won, et al.
Publicado: (2022)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
por: Seyyedmajidi, Mohamadreza, et al.
Publicado: (2019)

Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge
por: Akouh, Nada, et al.
Publicado: (2023)

Short-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori
por: Hasan, Salman R., et al.
Publicado: (2010)

Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2019)

Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children
por: Hong, Jeana, et al.
Publicado: (2012)

Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers
por: Lee, Chang Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_074bd4rai0sjahbtcokdfmmkem